IP Library Granted Patent US 8,137,396
Granted Patent B2
US 8,137,396 · App. 12/783,261 · Granted Mar 20, 2012

Medical implant

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,137,396
App. No.
12/783,261
Granted
Mar 20, 2012
Kind
B2
Abstract

Disclosed is a self-expanding medical implant for placement within a lumen of a patient. The implant comprises a woven or non-woven structure having a substantially tubular configuration, and is designed to be low-profile such that it is deliverable with a small diameter catheter. The implant has a high recoverability and desired mechanical properties.

Claims (16)

1. An implantable medical device, comprising:

a self-expanding tubular structure comprising

at least one biodegradable strand comprising poly(lactic acid-co-glycolic acid) comprising at least about 75 weight percent of lactic acid; and

poly(lactic acid-co-caprolactone) at least partially coating said strand;

wherein said poly(lactic acid-co-caprolactone) is crosslinked and has a number average molecular weight (Mn) greater than about 30,000 Da;

wherein said poly(lactic acid-co-caprolactone) increases the mass of said self-expanding tubular structure by at least about 24 percent;

wherein said self-expanding tubular structure is a braided structure comprising between 16 and 48 strands forming an average braid angle of between about 110 degrees and about 135 degrees.

2. The implantable medical device of claim 1 , wherein said poly(lactic acid co-glycolic acid) comprises at least about 85 weight percent of lactic acid.

3. The implantable medical device of claim 1 , wherein said at least one biodegradable strand is characterized by a modulus of elasticity greater than about 6 GPa.

4. The implantable medical device of claim 1 , wherein said poly(lactic acid-cocaprolactone) is crosslinked with hexamethylene diisocyanate.

5. The implantable medical device of claim 1 , wherein the number average molecular weight (Mn) of said poly(lactic acid-co-caprolactone) is greater than about 24,000 Da and less than about 100,000 Da.

6. The implantable medical device of claim 1 , wherein said poly(lactic acid-cocaprolactone) is characterized by an elastic segment having a glass transition temperature less than about 5° C.

7. The implantable medical device of claim 1 , further comprising a therapeutic agent within at least one of said poly(lactic acid-co-glycolic acid) and said poly(lactic acid-cocaprolactone).

8. The implantable medical device of claim 1 , further comprising an additional polymer at least partially coating said poly(lactic acid-co-caprolactone).

9. The implantable medical device of claim 8 , further comprising a therapeutic agent within said additional polymer.

10. The implantable medical device of claim 1 , wherein said poly(lactic acid-co-caprolactone) comprises a first segment having a Tg less than about 5° C. and a second segment that is harder than the first segment.

Assignments (4)
CHANGE OF NAME Recorded Jan 17, 2020
From: 480 BIOMEDICAL, INC.
To: LYRA THERAPEUTICS, INC.
Reel/Frame 051637/0116 →
CHANGE OF NAME Recorded Feb 15, 2012
From: ARSENAL MEDICAL, INC.
To: ARSENAL VASCULAR, INC.
Reel/Frame 027705/0758 →
CHANGE OF NAME Recorded Feb 15, 2012
From: ARSENAL VASCULAR, INC.
To: 480 BIOMEDICAL, INC.
Reel/Frame 027705/0770 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 3, 2010
From: BUSOLD, RANY; YOU, CHANG CHENG; CONCAGH, DANIEL; CORE, LEE; HO, KICHERI; PALASIS, MARIA; SHARMA, UPMA; ZUGATES, GREG
To: ARSENAL MEDICAL, INC.
Reel/Frame 024780/0943 →